Brief: Impact BioMedical Announces Issuance Of Canadian Patent For Linebacker Technology Targeting Inflammatory Disease
15/10/2024 11:22
Oct 15 (Reuters) - Impact Biomedical Inc IBO.A :
* IMPACT BIOMEDICAL INC. ANNOUNCES ISSUANCE OF CANADIAN
PATENT FOR
LINEBACKER™ TECHNOLOGY TARGETING INFLAMMATORY DISEASE
* IMPACT BIOMEDICAL INC - CANADIAN PATENT TERM EXPIRES IN
MAY 2037
Source text for Eikon: ID:nGNX11gl73
Further company coverage: IBO.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Impact Biomedical
See all newsBrief: Impact BioMedical Announces 1 For 12.62 Reverse Stock Split To Pursue Completion Of Merger With Zoar
Brief: Impact Biomedical Says On July 21 Entered Debt Conversion Agreement With DSS
Brief: Dr Ashleys Limited And Impact Biomedical Inc. Announce Strategic Merger
Brief: Impact BioMedical Announces Issuance Of Canadian Patent For Linebacker Technology Targeting Inflammatory Disease
Brief: Impact Biomedical Inc. Announces Pricing Of Initial Public Offering